期刊
BRITISH JOURNAL OF RADIOLOGY
卷 89, 期 1062, 页码 -出版社
BRITISH INST RADIOLOGY
DOI: 10.1259/bjr.20150943
关键词
-
资金
- Sirtex Medical Singapore
- Oncosil Pte Ltd
- Psivida Pte Ltd
- Sirtex Medical
- Bayer Pharmaceutical
In recent years, yttrium-90 (Y-90) microsphere radioembolization has been establishing itself as a safe and efficacious treatment for both primary and metastatic liver cancers. This extends to both first-line therapies as well as in the salvage setting. In addition, radioembolization appears efficacious for patients with portal vein thrombosis, which is currently a contraindication for surgery, transplantation and transarterial chemoembolization. This article reviews the efficacy and expanding use of Y-90 microsphere radioembolization with an added emphasis on recent advances in personalized dosimetry and interventional radiology techniques. Directions for future research into combination therapies with radioembolization and expansion into sites other than the liver are also explored.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据